SMTL ID : 8boi.1

Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 9

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.63 Å

Oligo State

monomer

Ligands

1 x R0O: 4-methyl-~{N}-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide(Non-covalent)

R0O.1: 30 residues within 4Å: Chain A: I.25, G.26, A.27, V.33, A.50, I.51, K.52, E.69, I.72, M.73, F.76, I.81, I.82, I.96, I.97, T.98, E.99, Y.100, M.101, G.104, L.136, Y.141, V.142, H.143, R.144, L.152, V.161, S.162, D.163, F.164 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:V.33, A:K.52, A:E.69, A:I.72, A:I.96, A:T.98, A:L.152, A:D.163, A:D.163, A:F.164 Hydrogen bonds: A:E.69, A:T.98, A:M.101, A:D.163 Salt bridges: A:D.163 pi-Cation interactions: A:H.143 Halogen bonds: A:V.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Troster, A. et al., Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor. Chemistry (2023)

Release Date

2023-03-08

Peptides

Ephrin type-A receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ephrin type-A receptor 2

Related Entries With Identical Sequence